D-0494-2020 Class II Terminated
FDA drug recall D-0494-2020 was initiated by Washington Homeopathic Products, Inc. on November 8, 2019 and is designated Class II. Reason for recall: CGMP Deviations: products were not manufactured under current good manufacturing practices. The recall status is terminated (terminated January 4, 2023). Affected quantity: 829 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- November 27, 2019
- Initiation Date
- November 8, 2019
- Termination Date
- January 4, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 829 bottles
Product Description
Cell Salts Combination 6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV 25411, barcode 7 40640 64200 9.
Reason for Recall
CGMP Deviations: products were not manufactured under current good manufacturing practices.
Distribution Pattern
Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia
Code Information
Lot #: BC18C142 and BC18G056